In recent years, renal collecting duct-specific endothelin-1 (ET1), endothelin A (ETA) and endothelin B (ETB) receptors as well as nitric oxide synthase 1 (NOS1) knockout mice have been developed with subsequent identification for an integral role in regulation of sodium water homeostasis and ultimately blood pressure. The focus of this review is to integrate these models and to propose a scheme for the control of sodium excretion by the collecting duct and the endothelin/ETB/NOS system.
INTRODUCTION
In recent years, advances have been made in the research area of sodium and water homeostasis through the development of collecting duct principal cell knockouts. These include genetic deletion from the collecting duct of endothelin-1 (ET1), endothelin A receptor (ETA) and endothelin B receptor (ETB). Most recently, we deleted nitric oxide synthase-1 (NOS1) from the collecting duct of the mouse. From these different models, it is evident that ET1/nitric oxide signalling in the collecting duct regulates sodium and water homeostasis. Clinically, what these studies have directly illuminated is that collecting duct ET1/nitric oxide is necessary for blood pressure regulation.
NITRIC OXIDE AND NITRIC OXIDE SYNTHASE IN THE COLLECTING DUCT
In the mouse collecting duct, NOS1 (neuronal NOS, nNOS) and NOS3 (endothelial NOS, eNOS) are expressed. In addition, NOS2 (inducible NOS) mRNA was described from the rat inner medullary collecting duct (IMCD) [1] and was recently detected in the IMCD of lipopolysaccharide-treated rats [2] . The IMCD has the greatest total NOS activity out of all the regions of the rat kidney [1] . Physiological stimuli, such as an increase in shear stress, lead to significant increases in IMCD nitric oxide production [3] . Shear stress in the tubule is increased in states of increased urine flow, such as the ones experienced during consumption of high-salt diets [3] , and this is hypothesized to be one of the mechanisms in nitric oxide-dependent natriuresis/ diuresis. Shear stress also increases ATP release from the cortical collecting duct (CCD) and this leads to increases in intracellular calcium via purinergic activation of transient receptor potential vanilloid (TRPV)4 channels [4] . Exogenous nitric oxide inhibits flow-mediated TRPV4 increases in intracellular calcium via a protein kinase G-mediated event in M1-CCD cells (an in-vitro cell line) [5] . These data suggest that flow-mediated nitric oxide may limit flow-mediated ATP/TRPV4 increase in intracellular calcium. The authors [5] speculate that nitric oxide inhibition of intracellular calcium may have a profound effect on sodium transport through inhibition of calcium-sensitive ion transporters, but this remains to be tested.
ATP/P2Y2 signalling also decreases blood pressure and promotes sodium excretion [6] through inhibition of the epithelial sodium channel (ENaC) [7] . The functions of ATP on inhibiting sodium reabsorption are similar to those of nitric oxide, so are these signalling pathways integrated? Nitric oxide mediates the inhibitory effect of extracellular ATP on collecting duct apical K þ channels [8] ; thus, it is plausible that nitric oxide mediates the effects of ATP on ENaC, but this remains to be tested.
Medullary NOS1 has been hypothesized to be involved in the regulation of blood pressure. Infusion of NOS1 antisense oligonucleotides or NOS1 pharmacological inhibitors into the medulla of the rat results in a significant increase in blood pressure when the rats were fed a high-salt diet [9] . Surprisingly, the commercially available total body NOS1 (exon 2) knockout mouse is normotensive, even on a high-salt diet [10] . What is still not well understood is that NOS1 expresses multiple splice variants ( Fig. 1 ) [11] . NOS1a is the full length variant and the first described NOS enzyme with a molecular weight of 160 kDa. NOS1b and NOS1g are alternatively spliced and lack exon 2, thus producing N-truncated variants that lack a PDZ domain and have a molecular weight of 130 and 125 kDa, respectively [11, 12] . These splice variants are differentiated by molecular weight with western blots and the use of C-terminus antibodies. NOS1b possesses activity comparable to NOS1a, whereas NOS1g has only approximately 3% of the enzymatic activity [11, 12] . In addition, there is a NOS1 splice variant with a 102-bp insertion between exon 16 and 17, resulting in a 34-amino acid addition [13] . This variant is termed NOS1m and is expressed in skeletal muscle and heart [13] . NOS1 splice variants have been described in the kidney, with a high proportion of the mRNA being NOS1b [14] . Recently, it was determined that the rat cortex [15] and macula densa [16] express NOS1a and NOS1b. Furthermore, the rat medulla [15] and IMCD [17] express NOS1a and NOS1b. However, in the mouse IMCD or in mIMCD-3 cells (an in-vitro mouse IMCD cell culture line), predominantly NOS1b is expressed [17] . The commercially available NOS1 knockout mouse is a NOS1a knockout mouse because it was targeted at exon 2 [18] . A total NOS1 knockout mouse (targeted at exon 6) was developed, but these mice have severe developmental abnormalities and KEY POINTS NOS1 splice variants are physiological regulators of sodium excretion.
Flow regulation of ET1 involves mitochondrial Na þ / Ca 2þ exchanger, which is a novel regulatory pathway for ET1 or any autocrine/paracrine peptide. ET1 signalling pathways involve NOS1 splice variants, NOS1b in the mouse collecting duct and NOS1a and NOS1b in the rat collecting duct.
The generation of collecting duct specific endothelin system and NOS1 knockout models has lead to discoveries in the regulation of water and sodium homeostasis, highlighting these as important targets for drug development in salt-sensitive hypertension. 
NOS1γ CTG FIGURE 1. Predicted nitric oxide synthase 1 splice variant mRNA from the mouse and predicted protein domains. NOS1, nitric oxide synthase 1. Modified from [11] .
only survive on a liquid diet [19] ; however, there are no reports of blood pressure in these mice.
During high dietary salt intake, urinary NOx (nitrite þ nitrate) excretion, an index of nitric oxide production, is increased in mice [20] [21] [22] [23] [24] , rats [25] [26] [27] and humans [28] [29] [30] . Low levels of urinary NOx excretion correlate with the progression of hypertension in humans [31] . Recent studies have aimed to determine whether the NOS1 splice variants are regulated by dietary sodium. During challenge with a high-salt diet, NOS1b expression is increased in the rat macula densa, and NOS1a is reduced [16] , suggesting that NOS1b is a saltsensitive splice variant. In addition, Lu et al. [16] found a significant increase in macula densa nitric oxide, putatively derived from NOS1b, and attenuation of the tubuloglomerular feedback mechanism. This suggests that high-salt diet-induced NOS1bderived nitric oxide regulates sodium delivery through the nephron and sodium excretion, although this hypothesis needs to be tested directly. We have developed a collecting duct NOS1 (exon 6) knockout mouse (CDNOS1KO), and these mice display a salt-sensitive blood pressure phenotype (Hyndman et al., unpublished data). Moreover, switching the diet from sodium-deficient to a high-salt diet in the CDNOS1KO mice results in a significant blunting of urinary sodium excretion, NOx excretion and urine production (Hyndman et al., unpublished data). Thus, we speculate that similar to the macula densa, collecting duct NOS1b is critical in sodium and water homeostasis. We have further found that expression of the ENaC is significantly higher in the membrane fraction of renal tissue homogenates of the CDNOS1KO mice on a high-salt diet than in flox control mice (Hyndman et al., unpublished data). These data suggest that NOS1 in the collecting duct may directly regulate the trafficking of sodium channels and/or other transporters.
ENDOTHELIN-1 IN THE KIDNEY
ET1 and the endothelin receptors are most highly expressed in the renal collecting duct, in which ET1 functions as a diuretic/natriuretic factor. Recently, it was determined that aldosterone (a mineralocorticoid) and dexamethasone (a synthetic glucocorticoid), hormones involved in fluid-electrolyte homeostasis, regulate ET1 transcription through direct binding of the mineralocorticoid receptor and glucocorticoid receptor to the ET1 promoter in collecting duct cells [32] . What is intriguing about this finding is that aldosterone and dexamethasone promote sodium retention, which is opposite to the natriuretic effects of ET1. These data suggest that ET1 may prevent excess sodium retention by the mineralcorticoids and glucocorticoids in the collecting duct.
Work by the laboratory of David Pollock has highlighted the role of ETB receptor dysfunction in sodium excretion in two different models of increased angiotensin II (AngII): low salt diet [33] and AngII-hypertension model [34] . In both models, AngII via the Ang receptor 1 (AT1) results in a significant decrease in ETB-dependent natriuresis/ diuresis. In AngII hypertensive male rats, there is a significant downregulation of the ETB receptor (as determined by radioligand binding) [34] , although this was not true with the increased endogenous AngII induced by a low-salt diet [33] . Thus, the pathophysiological state (AngII hypertension) and physiological state (increased AngII with low salt) are driven by different mechanisms. What remains to be determined are the mechanisms of AT1dependent ETB receptor dysfunction, which will be vital for drug development.
Recent studies [35,36 && ] have determined that collecting duct ET1 production is regulated by flow, Na delivery, the ENaC and mitochondrial Na þ /Ca þ2 exchanger. Thus, extracellular fluid expansion and resultant increase in renal tubular flow (likely shear stress) are important physiological regulators of collecting duct ET1 production. Interestingly, the role of mitochondrial Na þ /Ca 2þ exchanger in the regulation of ET1 production is novel and will likely be the focus of many studies to come.
The Kohan laboratory has developed four principal cell collecting duct knockout mice of the endothelin system. They have genetically deleted ET1 [37, 38] , ETA receptor [39] , ETB receptor [40] and both ETA and ETB (ETA/ETB) receptors [41] . These studies were recently reviewed [42] , but to summarize, deletion of collecting duct ET1, ETB or ETA/ETB results in sodium retention and a significant salt-sensitive increase in blood pressure. Deletion of the ETA receptor had little effect on sodium excretion or blood pressure [39] . CDET1KO mice have an impaired ability to excrete a sodium load [38] . Furthermore, the CDETBKO mouse displays a blunted sodium excretion when given an acute salt load (intraperitoneally, i.p.) in the first 4 h after injection compared with flox control animals [40] . CDETBKO mice also present with reduced plasma renin activity on both normal and high-salt diets, suggesting that there is volume expansion in this model. Thus, collecting duct ET1 and ETB are integral in sodium balance and blood pressure regulation.
To examine the mechanism of the increased sodium retention in these models, a series of CCD patch clamp studies were completed to determine the effect of the ET1 system on ENaC activity. Exogenous ET1 significantly reduces ENaC activity (as measured by open probability, Po) in CCD of wild-type mice [43 & ] and rats [44] . The inhibition of ENaC by ET1 involves the src-extracellular signalregulated kinase (ERK)1/2 pathway [44] . Moreover, the CCD of the collecting duct ETBKO mice and CDETAKO/CDETBKO mice has increased Po compared with CCD from wild-type and CDETAKO mice [43 & ]. Thus, ET1 via the ETB receptor in the collecting duct inhibits ENaC activity and is, at least partially, part of the mechanism of sodium retention and salt-sensitive hypertension in the CDET1KO models.
In recent years, hypotheses about the regulation of circadian rhythm genes and their gene targets have increased. The ET1 gene was recently discovered to be negatively regulated by the clock gene, Per1 [45] , whereas transcription of ENaCa is positively regulated by Per1 [46] . Per1 knockout mice have a hypotensive phenotype with a significant increase in cortical and medullary ET1 production [45] . These data suggest that the lower blood pressure in Per1 knockout mice may be linked to increased ET1-dependent natriuresis/diuresis [45] .
ENDOTHELIN-NITRIC OXIDE INTERACTIONS IN THE COLLECTING DUCT
The endothelin-nitric oxide systems interact in the renal collecting duct. In mIMCD-3 cells, ET1 via the ETB receptor increases nitric oxide production but did not change NOS1 or NOS3 expression [47] . ET1 via ETB receptors also increased phosphorylation of ERK1/2; however, this pathway is independent of ETB-mediated nitric oxide production, as inhibition of ERK1/2 phosphorylation does not prevent the ET1-induced increase in mIMCD3 nitric oxide production [47] . Currently, it remains to be determined what is the mechanism of intracellular signalling that links ET1/ETB to NOS1 and NOS3 in the IMCD. It is possible that this is regulated by intracellular calcium, as has been shown in the rat thick ascending limb [48] . Moreover, it could be regulated by protein-protein interactions, as we recently reported that dynamin-2 interacts with collecting duct NOS1a and NOS1b in the rat collecting duct, and NOS1b in the mIMCD3, leading to a significant increase in nitric oxide production [17] . Preliminary experiments suggest that this interaction is regulated by intracellular calcium, whereby an increase in intracellular calcium significantly increases the dynamin-2/NOS1 interaction and nitric oxide production (Hyndman and Pollock, unpublished data). We are currently testing the hypothesis that ET1 regulates the dynamin-2/ NOS1 interaction in the IMCD and that this cascade is dependent on intracellular calcium (Fig. 2) . Finally, the role of dynamin/NOS interactions in sodium homeostasis needs to be addressed and may be a novel intervention for increasing endogenous nitric oxide in models deficient in nitric oxide, such as chronic kidney disease [15] .
In the rat IMCD suspensions, ET1 via the ETB receptor increased NOS1-derived nitric oxide production [49] . In these studies, it was not determined whether this increase in nitric oxide was from NOS1a or NOS1b, as both splice variants are expressed in the rat collecting duct [17] . In the CDET1KO mice, there is a significant reduction in urinary NOx excretion (nitric oxide metabolites) on both normal and high-salt diets [50] , again illustrating that ET1 basally signals through NOS1b in the mouse collecting duct (NOS1b is the major splice variant in the mouse collecting duct [17] differences in protein expression [50] . The collecting duct ET1/nitric oxide signalling pathway modulates pressure-natriuresis, as the CDET1KO mouse displays a significant blunting in sodium and NOx excretion when subjected to acute increases in blood pressure (provided by tightening ligatures around the celiac and mesenteric arteries) [50] . Our current studies are examining whether CDNOS1KO mice have a shifted pressure-natriuresis relationship to further support the hypothesis that the collecting duct NOS1-derived nitric oxide is a modulator of the pressure-natriuresis relationship. An increase in tubular flow results in an increase in shear stress against the tubular epithelium. An increase in shear has been determined to increase both ET1 [35,36 && ] and nitric oxide production [3] . In vivo, shear is increased during high dietary sodium consumption, wherein there is also a significant increase in water intake. The body excretes this excess sodium via two mechanisms: (1) pressurenatriuresis, and (2) direct tubular actions to inhibit sodium reabsorption. Why does the body need two mechanisms to promote natriuresis (positive feedback mechanisms), when increased interstitial pressure already results in natriuresis? Lyon-Roberts et al. [35] determined that with increased shear, there is sodium reabsorption via apical ENaC resulting in increased ET1 production, with subsequent inhibition of ENaC-mediated sodium reabsorption. These data suggest that if direct tubular mechanisms are dysfunctional to inhibit sodium reabsorption, then a portion of the filtered sodium load will be reabsorbed, however less efficient. Taken together, these data suggest that shear initially increases nitric oxide and inhibits collecting duct sodium reabsorption, but in times of prolonged natriuresis, an increase in ET1 may provide further protection against sodium reabsorption. Thus, pressure-natriuresis and direct inhibition of tubular reabsorption may proceed to work in tandem to promote efficient natriuresis. A hypothetical scheme of the ET1/nitric oxide interactions leading to regulation of sodium excretion in the collecting duct is depicted in Fig. 2 .
CONCLUSION
With the development of collecting duct specific ET1 and NOS1 knockout models, the roles of ET1 and nitric oxide in the regulation of sodium homeostasis have been illuminated. These models allow hypotheses to be tested on the cellular mechanisms of collecting duct sodium transport, and ultimately may lead to novel pathways for the treatment of salt-sensitive hypertension. Moreover, determining the physiological role of the NOS1 splice variants and their contribution to renal function in all parts of the kidney is an important next step to further our knowledge of nitric oxide diuretic and natriuretic effects. Many questions of how the NOS1 splice variants are regulated and their interaction with the endothelin system in all areas of the kidney need to be elucidated to fully 'kNOw' the 'A and B of endothelin' signalling of sodium homeostasis and blood pressure control.
